Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 5, Issue 4, 2006, Pages 261-263

  Adeboyeku, David ^a   Scott, Sandra ^a   Hodson, Margaret E ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Colistin; Cystic fibrosis; Nebulised antibiotics; Tobramycin

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; COLISTIMETHATE; COLISTIN; DEOXYRIBONUCLEASE; RECOMBINANT ENZYME; TOBRAMYCIN;

ADULT; ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; MALE; OPEN STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHRONIC DISEASE; COLISTIN; CROSS-OVER STUDIES; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PSEUDOMONAS INFECTIONS; TOBRAMYCIN;

EID: 34248358238     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.05.009     Document Type: Article

References (18)

1. Hoiby N. Cystic fibrosis and endobronchial pseudomonas infection. Curr Opin Pediatr 5 (1993) 247-254
2. Denton M., and Wilcox M.H. Antimicrobial treatment of pulmonary colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients. J Antimicrob Chemother 40 (1997) 468-474
3. Govan J.R.W., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60 (1996) 539-574
4. Fitzsimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
5. Clinical Guidelines for Cystic Fibrosis Care Working Party Recommendations. Cystic Fibrosis Trust, British Paediatric Association and British Thoracic Society, July 1996.
6. Henry R.L., Mellis C.M., and Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12 (1992) 158-161
7. Kerem E., Reisman J., Corey M., Canny G.L., and Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326 (1992) 1187-1191
8. Connett G.J. Respiratory management. In: Hill C.M. (Ed). Practical Guidelines for Cystic Fibrosis Care (1998), Churchill Livingstone 21-35
9. Frederiksen B., Koch C., and Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23 (1997) 330-335
10. Mendelman P.M., Smith A.L., Levy J., Weber A., Ramsey B., and Davis R.L. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 132 (1985) 761-765
11. Saiman L. Use of aerosolized antibiotics in patients with cystic fibrosis. Pediatr Infect Dis J 17 (1998) 158-159
12. Touw D.J., Brimcombe R.W., Hodson M.E., Heijerman H.G.M., and Bakker W. Inhalation of antibiotics in cystic fibrosis. Eur Respir J 8 (1995) 1594-1604
13. Webb A.K., and Dodd M.E. Nebulised antibiotics for adults with cystic fibrosis. Thorax 52 Suppl 2 (1997) S69-S71
14. Jensen T., Pedersen S.S., Garne S., Heilmann C., Hoiby N., and Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 19 (1987) 831-838
15. PathoGenesis Corporation. A phase III placebo-controlled clinical trial to study the safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis: PC-TNDS-002. Seattle, WA; 1997.
16. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 340 (1999) 23-30
17. Hodson M.E., Gallagher C.G., and Govan J.R.W. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20 (2002) 658-664
18. SAS/STAT Users guide. Version 8. Vol.2. Cary NC: SAS Institute Inc, 1999.